Drug intelligence / Profile preview

xiaoer fumai decoction

Development stage: Preclinical
Lead developer: Longhua Hospital Shanghai University of Traditional Chinese Medicine
Administration: Oral

Overview

Xiaoer Fumai Decoction is a Traditional Chinese Medicine (TCM) herbal preparation developed for pediatric use, primarily targeting arrhythmias such as premature ventricular contractions (PVCs). The formula is utilized in clinical research at institutions like Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine. It is designed to "restore the pulse" (Fumai) and is often evaluated in combination with other TCM modalities like press-needle therapy to reduce the frequency of ectopic beats and improve clinical symptoms in children. As a decoction, it is an aqueous extract of multiple medicinal herbs, administered orally.

Other names: Xiaoer Fumai TangXiaoer Fumai Formula

Beyond the preview

Go deeper on xiaoer fumai decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on xiaoer fumai decoction.

Explore the full profile